POMONA, Calif., June 27, 2024 /PRNewswire/ — Amsino Medical Group (“Amsino”), a global provider of medical consumable devices, is pleased to announce the closing of a substantial investment by Novo Tellus, a leading investment firm specialising in long-term investments in the global supply chain. Amsino Medical Group Company announces transformational investment from Novo Tellus Novo Tellus